IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
Provided By GlobeNewswire
Last update: Nov 5, 2024
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an upcoming poster presentation at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being hosted December 7 – 10, 2024 in San Diego, CA.
Read more at globenewswire.com0.1534
+0.01 (+8.03%)
Find more stocks in the Stock Screener
INAB Latest News and Analysis
3 days ago - ChartmillThese stocks are moving in today's after hours sessionLet's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
